COVID-19: Multisystem Inflammatory Syndrome

Although children rarely develop severe COVID-19 symptoms, a number of pediatric cases have been reported that associate SARS-CoV-2 infection with the development of a proinflammatory syndrome resembling Kawasaki disease and toxic shock syndrome. Ongoing research into this Multisystem Inflammatory Syndrome (MIS-C) is highlighted in this feed.

September 11, 2020
Open Access

COVID-19 acute myocarditis and Multisystem Inflammatory Syndrome in adult intensive and cardiac care units

Chest
Guillaume HékimianAlain Combes
September 10, 2020
Review
Open Access

COVID-19 infection-Risk of thromboembolic complications

Gefässchirurgie : Zeitschrift für vaskuläre und endovaskuläre Chirurgie : Organ der Deutschen und der Österreichischen Gesellschaft für Gefässchirurgie unter Mitarbeit der Schweizerischen Gesellschaft für Gefässchirurgie
S ZerwesA Hyhlik-Dürr
September 23, 2020
Open Access

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Science Translational Medicine
Carl A PierceBetsy C Herold
September 15, 2020
Open Access

The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review

Journal of the Pediatric Infectious Diseases Society
Stephen C AronoffMichael T Del Vecchio
September 9, 2020

Challenges in Diagnosing Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in a Child With Severe Neurocognitive Impairment and Social Isolation

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Danilo BuonsensoPiero Valentini
September 17, 2020
Review
Open Access

Kawasaki-like disease in children with COVID-19

Rheumatology International
Ummusen Kaya AkcaSeza Ozen
September 15, 2020

The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic

Acta Bio-medica : Atenei Parmensis
Francesca LamiLorenzo Iughetti
September 10, 2020
Review
Open Access

SARS-CoV-2 infections in children and young people

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Susanna Felsenstein, Christian M Hedrich
September 19, 2020
Open Access

Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America

The Pediatric Infectious Disease Journal
Rolando Ulloa-GutierrezAdriana H Tremoulet
September 22, 2020
Review
Open Access

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

The Lancet Child & Adolescent Health
Rachel HarwoodPIMS-TS National Consensus Management Study Group
September 14, 2020
Review
Open Access

On the genetics and immunopathogenesis of COVID-19

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Chaim Oscar Jacob
September 15, 2020

An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?

Acta Bio-medica : Atenei Parmensis
Federica Cavallo, Francesco Chiarelli
September 17, 2020
Open Access

Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey from the International Kawasaki Disease Registry

CJC Open
Matthew D EliasInternational Kawasaki Disease Registry
September 16, 2020
Preprint
Open Access

Adult post COVID-19 multisystem inflammatory syndrome and thrombotic microangiopathy

ResearchSquare
Idris BoudhabhayFranck Pourcine
September 15, 2020

A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection

The Pediatric Infectious Disease Journal
Ashlesha KaushikShikha Verma
September 17, 2020
Open Access

Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical Kawasaki

BMJ Case Reports
Mike MasihNaila Raza
September 19, 2020
Review
Open Access

SARS-CoV-2 and coagulation disorders in different organs

Life Sciences
Sathishkumar Vinayagam, Kamaraj Sattu

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2020 Meta ULC. All rights reserved
/feed-previews/covid-19-multisystem-inflammatory/73a6a0b8-d961-42a3-98f6-268d6281828e